The global fertility and pregnancy rapid test kit market is set for robust growth, with the market size valued at USD 948.3 million in 2022. According to industry projections, the market is expected to reach a valuation of USD 990.4 million by the end of 2023. Over the forecast period from 2023 to 2033, the market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 5%, achieving a significant valuation of USD 1,609.1 million by 2033.
This growth is driven by increasing awareness and demand for convenient and reliable home testing solutions for fertility and pregnancy. The rapid test kits offer a user-friendly and efficient way for individuals to monitor their reproductive health, contributing to their widespread adoption.
Request Your Detailed – Report Sample
Due to shifts in healthcare choices and increased awareness worldwide, the market for fertility and pregnancy test kits is expanding gradually but steadily. These kits give consumers the privacy, simplicity of use, and clarity they need to make informed decisions about their reproductive health.
Key Takeaways from the Market Analysis
- The fertility and pregnancy rapid test kit market developed at a 4% CAGR throughout the historical period.
- The market in the United States is expected to increase at a 5.2% CAGR over the forecast period.
- From 2023 to 2033, the fertility and pregnancy rapid test kit market in China is set to garner a 6% CAGR.
- The market in France is expected to increase at a 4.2% CAGR from 2023 to 2033.
- The fertility and pregnancy rapid test kit market in Japan is predicted to flourish at a 4.7% CAGR over the projected period.
- The market in the United Kingdom is forecast to advance at a 4.9% CAGR over the projected period.
- The pregnancy rapid test kit segment is anticipated to capture a CAGR of 4.5% through 2033.
- The hCG urine test segment is predicted to secure a CAGR of 6.2% from 2023 to 2033.
“The availability of at-home self-test kits, successful early pregnancy detection, and the affordability of fertility and pregnancy rapid test kit are additional benefits contributing to the overall growth of the market,”- remarks an FMI analyst.
Competitive Landscape
Manufacturers are evolving their product portfolios of fertility and pregnancy rapid test kit by launching new products. This covers various test sensitivity levels, formats (e.g., blood, digital, urine-based), and packaging choices (e.g., single-use kits, multi-pack alternatives).
Manufacturers may increase revenue and sales by catering to various consumer requirements and tastes through a wide range of products.
Prominent players in the fertility and pregnancy rapid test kit market are
- Alere Inc.
- Quidel Corporation
- Prestige Brands Holdings, Inc.
- Church & Dwight Co., Inc.
- bioMérieux SA
- Geratherm Medical AG
- Abbott Laboratories
- Procter & Gamble Co.
- DCC Plc.
- Swiss Precision Diagnostics GmbH
Customization Available: Here
Key Developments
- In 2022, to help individuals throughout their whole reproductive journey, Kindbody launched the Kind at Home fertility kits, its consumer goods business. Their first offering is an easy-to-use at-home fertility hormone test for both men and women.
With the Kind at Home fertility test kit, customers may conveniently obtain detailed information regarding their fertility status from the comfort of their own homes. Kindbody physicians make individualized suggestions that can be brought to the online or in-person clinic consultation with the patients.
- PregaScreen is a home pregnancy test kit that was introduced by Mylab Discovery Solutions. With this, the business has officially entered the female healthcare market. The kit is available for purchase over the counter at neighborhood pharmacies around the nation. It yields accurate findings in a matter of minutes. Pregnancy stick devices and droppers are included with every package.
- In 2023, Proov and 2San, a reputable global leader in self-diagnostic testing, teamed to provide the unique, simple-to-use, at-home fertility tests of Proove in a few Midwest Hy-Vee locations. With its four products—Reserve (follicle stimulating hormone), Predict (luteinizing hormone), Confirm (PdG), and Check (human chorionic gonadotropin)—their range of tests provides a thorough evaluation of fertility at an affordable price.
Segmentation Analysis of the Fertility and Pregnancy Rapid Test Kit Market:
By Product:
- Pregnancy Rapid Tests
- Line Indicator devices
- Strips/Dip Sticks
- Mid-Stream
- Cassettes
- Digital
- Line Indicator devices
- Fertility Rapid Tests
- Line Indicator
- Digital
By Test Type:
- LH Urine
- FSH Urine
- hCG Blood
- hCG Urine
By Distribution channel:
- Pharmacy
- Drugstore
- Gynecology/Fertility Clinics
- e-commerce
- Hypermarkets & Supermarkets
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East & Africa
In-Depth Market Analysis: Purchase Now to Access
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube